A genetic etiology of pervasive developmental disorder guides treatment

Am J Psychiatry. 2007 Apr;164(4):575-80. doi: 10.1176/ajp.2007.164.4.575.
No abstract available

Publication types

  • Case Reports
  • Clinical Conference
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Attention Deficit Disorder with Hyperactivity / epidemiology
  • Attention Deficit Disorder with Hyperactivity / genetics
  • Autistic Disorder / genetics
  • Autistic Disorder / therapy
  • Child
  • Child Development Disorders, Pervasive / epidemiology
  • Child Development Disorders, Pervasive / genetics
  • Child Development Disorders, Pervasive / therapy*
  • Comorbidity
  • Female
  • Fragile X Syndrome / epidemiology
  • Fragile X Syndrome / genetics
  • Fragile X Syndrome / therapy
  • Humans
  • Occupational Therapy / methods
  • Phenotype
  • Psychotherapy / methods
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Sertraline / therapeutic use

Substances

  • Serotonin Uptake Inhibitors
  • Sertraline